ES460623A1 - Procedimiento para la preparacion de nuevos derivados de ci-clopentano. - Google Patents

Procedimiento para la preparacion de nuevos derivados de ci-clopentano.

Info

Publication number
ES460623A1
ES460623A1 ES460623A ES460623A ES460623A1 ES 460623 A1 ES460623 A1 ES 460623A1 ES 460623 A ES460623 A ES 460623A ES 460623 A ES460623 A ES 460623A ES 460623 A1 ES460623 A1 ES 460623A1
Authority
ES
Spain
Prior art keywords
radical
hydrogen
prostaglandins
manufacture
translation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES460623A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES460623A1 publication Critical patent/ES460623A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/081,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02Five-membered rings
    • C07D339/06Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4018Esters of cycloaliphatic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES460623A 1976-07-16 1977-07-11 Procedimiento para la preparacion de nuevos derivados de ci-clopentano. Expired ES460623A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2632097A DE2632097C2 (de) 1976-07-16 1976-07-16 Cyclopentanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
ES460623A1 true ES460623A1 (es) 1978-05-16

Family

ID=5983219

Family Applications (1)

Application Number Title Priority Date Filing Date
ES460623A Expired ES460623A1 (es) 1976-07-16 1977-07-11 Procedimiento para la preparacion de nuevos derivados de ci-clopentano.

Country Status (13)

Country Link
JP (1) JPS5334754A (de)
AU (1) AU2705677A (de)
BE (2) BE856914A (de)
DE (1) DE2632097C2 (de)
DK (1) DK322177A (de)
ES (1) ES460623A1 (de)
FR (1) FR2358392A1 (de)
GB (1) GB1589525A (de)
IL (1) IL52523A0 (de)
LU (1) LU77767A1 (de)
NL (1) NL7707695A (de)
SE (1) SE7708245L (de)
ZA (2) ZA774254B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2834249A1 (de) * 1978-08-04 1980-02-28 Hoechst Ag Neue prostaglandinderivate in der delta 2-11-desoxy-pgf tief 2 bzw. pge tief 2 -reihe
US20230097470A1 (en) * 2021-08-23 2023-03-30 Chirogate International Inc. Processes and intermediates for the preparations of carboprost and carboprost tromethamine, and carboprost tromethamine prepared therefrom

Also Published As

Publication number Publication date
FR2358392B1 (de) 1980-02-08
FR2358392A1 (fr) 1978-02-10
JPS6218548B2 (de) 1987-04-23
NL7707695A (nl) 1978-01-18
ZA774255B (en) 1978-06-28
LU77767A1 (de) 1978-02-08
BE856914A (fr) 1978-01-18
AU2705677A (en) 1979-01-18
GB1589525A (en) 1981-05-13
DK322177A (da) 1978-01-17
JPS5334754A (en) 1978-03-31
BE856910A (fr) 1978-01-18
DE2632097A1 (de) 1978-01-19
SE7708245L (sv) 1978-01-17
IL52523A0 (en) 1977-10-31
DE2632097C2 (de) 1985-08-14
ZA774254B (en) 1978-06-28

Similar Documents

Publication Publication Date Title
ES461299A1 (es) Un procedimiento de preparacion de un compuesto de amonio cuaternario soluble en agua.
ES388869A1 (es) Un procedimiento para la preparacion de compuestos de del- ta3-cefalosporina.
ES456541A1 (es) Procedimiento para la preparacion de acidos n-fosfonometilen-monoaminoalcanmonofosfonicos y -polifosfonicos yno acidos n-fosfonometilen-diaminoalcanpolifosfonicos.
AU531714B2 (en) Prostaglandin derivatives of the delta2,4-11-deoxy-peg series
GB1141772A (en) 13-alkylgonahexaenes
ES460623A1 (es) Procedimiento para la preparacion de nuevos derivados de ci-clopentano.
ES472276A1 (es) Un procedimiento para la preparacion de un grupo de cis-4a- aril-octahidro-1h-2-pirindinas 2-sustituidas
ES449893A1 (es) Procedimiento de preparacion de aldehidos alfa, beta-etile- nicos.
ES438364A1 (es) Procedimiento para la obtencion de nuevos derivados de gen- tamicina.
ES444490A1 (es) Procedimiento para la fabricacion de n-fosfono-metilglicina y sus intermedios.
ES460608A1 (es) Procedimiento para la preparacion de nuevos derivados de ci-clopentano.
ES459871A1 (es) Procedimiento para la obtencion de sales de hidrocarbil-tio-etilaminas.
ES467861A1 (es) Procedimiento de preparacion de espiro-oxazolidinas esteroi-des y sus esteroisomeros.
ES462783A1 (es) Procedimiento para la produccion de dibenzo(d,b)piranos.
ES445263A1 (es) Un procedimiento para preparar un nuevo derivado de dimer- captoetileter.
ES465346A1 (es) Procedimiento para preparar imidazoles 4,5-disustituidos.
SE7600729L (sv) Prostaglandinforeningar
ES452299A1 (es) Procedimiento para la preparacion de nuevos derivados de ci-clohexano analogos a prostaglandina.
ES8102110A1 (es) Procedimiento para la preparacion de acido 1,2,3-tiadiazol- 5-il-tioglicolico
JPS5249925A (en) Fe-cr-co magnet alloy
ES442051A1 (es) Procedimiento para preparar aminoglicosidos de 2-deoxies- treptamina.
ES459400A1 (es) Un procedimiento para la produccion de nuevos compuestos de 6,11-dihidrodibenzo (b.e.) tiepin-11-ona.
ES465761A1 (es) Procedimiento para la obtencion de compuestos de acido 3-ha-logenosulfonil-tiofen-carboxilico.
ES454348A1 (es) Un procedimiento de preparacion de nuevos derivados del aci-do protanoico.
ES473381A1 (es) Procedimiento para la preparacion de nuevos derivados de prostaglandinas que contienen fluor.